Cardiff Oncology, Inc. (CRDF) vs LENSAR Inc (LNSR)
A side-by-side comparison of Cardiff Oncology, Inc. and LENSAR Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRDF
Cardiff Oncology, Inc.
$1.07HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
LNSR
LENSAR Inc
$6.70HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CRDF vs LNSR
growth of $100 · dividends reinvested · last 6yCRDF -92.0% (-34.3%/yr)LNSR -25.9% (-4.9%/yr)LNSR compounded faster over this window
Log scale — wide-divergence pair
CRDF LNSR
CRDF vs LNSR: by the numbers
- •CRDF is the larger company ($82M vs $82M market cap).
- •LNSR is profitable (57.57% net margin) while CRDF runs a net loss (-7884.06%).
- •LNSR grew revenue faster over the past five years (14.67% vs 5.15% CAGR).
Metrics side by side
Valuation
| Metric | CRDF | LNSR |
|---|---|---|
| P/S ratio | 162.34 | 1.37 |
| P/B ratio | 3.11 | 5.52 |
Profitability
| Metric | CRDF | LNSR |
|---|---|---|
| Gross margin | 100.00% | 47.96% |
| Operating margin | -8256.32% | -42.06% |
| Net margin | -7884.06% | 57.57% |
| ROE | -150.95% | 232.78% |
| ROIC | -159.30% | -16.28% |
Growth (annualized)
| Metric | CRDF | LNSR |
|---|---|---|
| Revenue CAGR (5Y) | 5.15% | 14.67% |
| Total return CAGR (5Y) | -30.36% | -3.18% |
Frequently asked
- Which has grown faster, CRDF or LNSR?
- Over the past five years, LNSR grew revenue faster — CRDF at a 5.15% CAGR versus LNSR at 14.67%.
- Is CRDF or LNSR more profitable?
- LNSR runs the higher net margin — CRDF at -7884.06% versus LNSR at 57.57%.
- How have CRDF and LNSR total returns compared?
- Over the past 5 years, CRDF delivered -30.36% and LNSR delivered -3.18% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cardiff Oncology ROELENSAR ROECardiff Oncology operating marginLENSAR operating marginCardiff Oncology revenue growthLENSAR revenue growthCardiff Oncology free cash flowLENSAR free cash flow
Cardiff Oncology & LENSAR appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.